Zoeken
Zoeken kan via de modus 'eenvoudig zoeken' (één veld) of uitgebreid via 'geavanceerd zoeken' (meerdere velden). Zo kan je bv. zoeken op een combinatie van een auteursnaam (auteur), een jaartal (jaar) en een documenttype.
Boekenmand
Nuttige resultaten kan je aanvinken en toevoegen aan een mandje. De inhoud hiervan kan je exporteren of afdrukken (naar bv. PDF).
RSS
Op de hoogte blijven van nieuw toegevoegde publicaties binnen uw interessegebied? Dit kan door een RSS-feed (?) te maken van jouw zoekopdracht.
nieuwe zoekopdracht
Marine anticancer agents: an overview with a particular focus on their chemical classes
Barreca, M.; Spanò, V.; Montalbano, A.; Cueto, M.; Díaz Marrero, A.R.; Deniz, I.; Erdogan, A.; Lukic Bilela, L.; Moulin, C.; Taffin-de-Givenchy, E.; Spriano, F.; Perale, G.; Mehiri, M.; Rotter, A.; Thomas, O.P.; Barraja, P.; Gaudêncio, S.P.; Bertoni, F. (2020). Marine anticancer agents: an overview with a particular focus on their chemical classes. Mar. Drugs 18(12): 619. https://dx.doi.org/10.3390/md18120619
In: Marine Drugs. Molecular Diversity Preservation International (MDPI): Basel. ISSN 1660-3397; e-ISSN 1660-3397
|   |
| Trefwoord |
|
| Author keywords |
marine natural products; marine drugs; anticancer; drug discovery; clinical pipeline |
| Auteurs | | Top |
- Barreca, M.
- Spanò, V.
- Montalbano, A.
- Cueto, M.
- Díaz Marrero, A.R.
- Deniz, I.
|
- Erdogan, A.
- Lukic Bilela, L.
- Moulin, C.
- Taffin-de-Givenchy, E.
- Spriano, F.
- Perale, G.
|
- Mehiri, M.
- Rotter, A.
- Thomas, O.P.
- Barraja, P.
- Gaudêncio, S.P.
- Bertoni, F.
|
| Abstract |
The marine environment is a rich source of biologically active molecules for the treatment of human diseases, especially cancer. The adaptation to unique environmental conditions led marine organisms to evolve different pathways than their terrestrial counterparts, thus producing unique chemicals with a broad diversity and complexity. So far, more than 36,000 compounds have been isolated from marine micro- and macro-organisms including but not limited to fungi, bacteria, microalgae, macroalgae, sponges, corals, mollusks and tunicates, with hundreds of new marine natural products (MNPs) being discovered every year. Marine-based pharmaceuticals have started to impact modern pharmacology and different anti-cancer drugs derived from marine compounds have been approved for clinical use, such as: cytarabine, vidarabine, nelarabine (prodrug of ara-G), fludarabine phosphate (pro-drug of ara-A), trabectedin, eribulin mesylate, brentuximab vedotin, polatuzumab vedotin, enfortumab vedotin, belantamab mafodotin, plitidepsin, and lurbinectedin. This review focuses on the bioactive molecules derived from the marine environment with anticancer activity, discussing their families, origin, structural features and therapeutic use. |
IMIS is ontwikkeld en wordt gehost door het VLIZ.
